AlphaFold predicted structure
MSH3 · P20585

Mean pLDDT
78.8/ 100
Confident
1,137 residues
Confidence breakdown
- Very high(≥ 90)59%
- Confident(70–90)15%
- Low(50–70)5%
- Very low(< 50)22%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
mutS homolog 3
Annotations refreshed 1 month ago.
Moderate Evidence (Amber)
Inherited polyposis and early onset colorectal cancer - germline testing
BIALLELIC, autosomal or pseudoautosomalGI tract tumours
BIALLELIC, autosomal or pseudoautosomalfamilial adenomatous polyposis 4
endometrial carcinoma
hereditary neoplastic syndrome
Inherited cancer-predisposing syndrome
endometrial cancer
endometrial neoplasm
neurodegenerative disease
X-linked dystonia-parkinsonism
response to simvastatin
response to fenofibrate
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
DNA mismatch repair protein Msh3
Component of the post-replicative DNA mismatch repair system (MMR). Heterodimerizes with MSH2 to form MutS beta which binds to DNA mismatches thereby initiating DNA repair. When bound, the MutS beta heterodimer bends the DNA helix and shields approximately 20 base pairs. MutS beta recognizes large insertion-deletion loops (IDL) up to 13 nucleotides long. After mismatch binding, forms a ternary complex with the MutL alpha heterodimer, which is thought to be responsible for directing the downstream MMR events, including strand discrimination, excision, and resynthesis
MSH3 · P20585

Mean pLDDT
78.8/ 100
Confident
1,137 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0